Abstract: The invention provides a nozzle assembly for spraying a food product. The nozzle assembly includes a first sprayer disposed along an axis defining, at least in part, a path of movement for a food product. The nozzle assembly also includes a second sprayer disposed along the axis. The second sprayer is axially and radially spaced from the first sprayer. The nozzle assembly also includes a cavity operable to receive edible ink. The cavity communicates directly with the first and second sprayers disposed along the axis. The first and second sprayers concurrently spray the edible ink from the cavity to the axis.

Abstract: An electronic device and method includes a means for setting a time interval for collecting a set of physiological data and entering the number of physiological events that occur within that time interval. The device and method are further configured to calculate the number events that occurred per minute, and displays the results for the user. The device may be implemented as a hand-held device and the method implemented in a graphical user interface of an electronic device.

Abstract: A thermal management system (101), comprising (a) a synthetic jet actuator (103), and (b) a processor (107) in communication with the synthetic jet actuator, the processor being adapted to receive programming instructions, and being further adapted to modify the operation of the synthetic jet actuator in response to the programming instructions.

Abstract: A blood pressure cuff is provided for use with a blood pressure monitoring system. The cuff includes a flexible elongated inflatable and deflatable sleeve sized to wrap around an individual's limb with the sleeve having opposite ends. A first fastener is attached on one of the sleeve ends and has at least one first fastening element. A second fastener is secured on the opposite sleeve end for attachment to the first fastener and has a plurality of spaced apart second fastening elements defining discrete closure positions. The second fastening elements are selectively receivable and separable with the at least one first fastening element to provide a desired closure of the sleeve at the discrete positions over a range of proper cuff sizing. One of the first and second fasteners is provided with a release handle enabling detachment of the first and second fasteners.

Abstract: A vital sign monitoring system that can be used with multiple patients and utilizes historic patient data information for the patient to optimize the process of obtaining current vital sign measurements. Each patient is identified with a unique patient identification device that is automatically detected by the vital sign monitor. The vital sign monitor communicates with a medical records database and obtains historic patient data information for the patient identified by the patient identification device. The historic patient data information can be utilized by the vital sign monitor to set alarm limits for the vital sign measurements and automatically control the operation of an NIBP monitor for the specific patient.

Abstract: The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders.

Abstract: An apparatus, system and method for collecting non-invasive blood pressure readings from a patient is provided. A non-invasive blood pressure cuff is arranged to be worn about a wrist of a patient and to be operatively connected to a blood pressure monitor. Communication means are operatively connected to the blood pressure cuff the monitor and arranged to automatically communicate a parameter associated with the cuff to the monitor. The monitor is arranged to automatically adjust blood pressure algorithms based upon the parameter to enhance the accuracy of blood pressure readings.

Abstract: An apparatus, system and method for collecting non-invasive blood pressure readings from a patient is provided. A non-invasive blood pressure cuff is arranged to be worn about a wrist of a patient and to be operatively connected to a blood pressure monitor. Communication means are operatively connected to the blood pressure cuff the monitor and arranged to automatically communicate a parameter associated with the cuff to the monitor. The monitor is arranged to automatically adjust blood pressure algorithms based upon the parameter to enhance the accuracy of blood pressure readings.

Abstract: This invention relates to pyrrolocarbazole derivatives according formula I wherein R1, R2, R7, R8, R9, X and Y are as defined in the specification wherein said derivatives specifically inhibit one or both of the checkpoint kinases Wee1 and Chk1

Abstract: Disclosed are compounds of the formula wherein R2, R5, R6, R7, and R8 are as defined herein. These compounds and their pharmaceutical compositions are useful for treating cell proliferative disorders, such as cancer and restenosis. These compounds are potent inhibitors of cdks and growth factor-mediated kinases.

Abstract: The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders.

Abstract: A print medium is printed on with a printhead of an ink jet printer. The print medium is advanced in an advance direction a predetermined amount. The print medium is printed on with the printhead in an area corresponding to the predetermined amount. A determination is made of an end of printable area on the print medium in the advance direction. The print medium is advanced in the advance direction a minimum reliable move amount, dependent upon the end of printable area determination. The minimum reliable move amount is less than the predetermined amount. The print medium is printed on with the printhead in an area corresponding to the minimum reliable move amount.

Abstract: A method of printing with an ink jet printer includes providing a printhead having a plurality of first nozzles with a first size and a plurality of second nozzles with a second size larger than the first size. The first nozzles and the second nozzles are alternatingly disposed in a vertical direction. Print data corresponding to first columns of pixel locations is provided. The print data includes for each pixel location in the first columns both a respective large dot print datum and a respective small dot print datum. One of the respective large dot print datum and the respective small dot print datum is printed at a first pixel location of the corresponding pixel locations in the first columns. Second columns of pixel locations interleaved with the first columns of pixel locations are provided.

Abstract: The invention provides a nozzle assembly for spraying a food product. The nozzle assembly includes a first sprayer disposed along an axis defining, at least in part, a path of movement for a food product. The nozzle assembly also includes a second sprayer disposed along the axis. The second sprayer is axially and radially spaced from the first sprayer. The nozzle assembly also includes a cavity operable to receive edible ink. The cavity communicates directly with the first and second sprayers disposed along the axis. The first and second sprayers concurrently spray the edible ink from the cavity to the axis.

Abstract: An isolated nucleic acid fragment encoding a diverged delta-9 fatty acid desaturase is disclosed. Also the construction of a chimeric gene encoding all or a portion of the diverged delta-9 fatty acid desaturase is disclosed, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the diverged delta-9 fatty acid desaturase in a transformed host cell.

Abstract: This invention provides pyridopyrimidines and 4-aminopyrimidines that are useful for treating cell proliferatives disorders, such as cancer and restenosis. We have now discovered a group of 7,8-dihydro-2 (amino and thio)pyrido[2,3-d]pyrimidines and 2,4-diaminopyrimidines that are potent inhibitors of cyclin-dependent kinases (cdks) and growth factor-mediated kinases. The compounds are readily synthesized and can be administered by a variety of routes, including orally, and have sufficient bioavailability. This invention provides compounds of Formula (I) and Formula (II) where W is NH, S, SO, or SO2, R1 includes phenyl and substituted phenyl, R2 includes alkyl and cycloalkyl, R3 includes alkyl and hydrogen, R8 and R9 include hydrogen and alkyl, and Z is carboxy. This invention also provide pharmaceutical formulations comprising a compound of Formula (I or II) together with a pharmaceutically acceptable carrier, diluent, or excipient therefor.

Abstract: The present invention provides a compound of the formula and pharmaceutically acceptable salts having useful antiviral activity against viruses of the herpes family. Wherein: X=O, (CH2)m, S, SO, SO2, NH, NR8; Y=O, (CH2)m, S, SO, SO2, NH, NR8 or a chemical bond; Z=NH, O, NR8, S, SO, SO2; The remaining substituents are described in the specification.

Abstract: A system and method for controlling a print job in a printer, such as canceling the print job held in the printer. The system includes a printer having a processor that receives print jobs, including one or more print data swaths, from one or more host computers, and each print data swath includes at least a predefined group of characters. The system also has at least one host computer in communication with the printer and which selectively sends print jobs including print data and/or command data. The host computer further selectively sends a command which is a predetermined group of characters within the print data swath, and the command alters a function in the printer. The command is preferably a series of identical characters, such as NULL characters, and the command preferably causes the printer to enter a command mode to execute the commanded function.

Abstract: The present invention provides compounds having the Formula I The present invention also provides pharmaceutical compositions comprising a compound of Formula I and methods of treatment of atherosclerosis, obesity, restenosis, coronary heart disease, hyperlipoproteinemia, hypercholesterolemia, and hypertriglyceridemia.

Abstract: Benzenesulfonamides of formula (I), in which W is OR1, NR2OR1, NRARB, NR2NRARB, or NR2(CH2)2-4NRARB and the other variables as defined in the claims, are inhibitors of MEK and are effective in the treatment of proliferative diseases, cancer, stroke, heart failure, xenograft rejection, arthritis, cystic fibrosis, hepatomegaly, cardiomegaly, Alzheimer's disease, complications of diabetes, septic shock, and viral infection.